Newsroom
Latest News from UNC Lineberger
-
UNC named organizational member of the American Cancer Society National Prostate Cancer RoundtableMembers participate in strategy development, professional education, and implementation efforts designed to influence policy, improve clinical practice, and promote evidence-based care across the prostate cancer continuum. -
UNC School of Medicine oncologist named recipient of Winn Clinical Investigator Leadership AwardYara Abdou, MD, is among the third cohort of physician researchers to receive the Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award. -
Inaugural Endometrial Cancer Center of Excellence retreat strengthens fight against endometrial cancerPhysicians, trainees and patient advocates gathered for the first UNC Lineberger Endometrial Cancer Center of Excellence retreat to discuss advancing research and clinical care for endometrial cancer. -
Against the Odds: Young Researchers Confront Pancreatic CancerA new generation of investigators is tackling one of oncology’s most persistent puzzles. Three of these young scientists discuss the rewards and challenges of committing their futures to this field … Read more -
What every woman needs to know about ovarian cancerLinda Van Le, MD, a UNC Health gynecologic oncologist, shares the warning signs of ovarian cancer. The lack of screening and vague symptoms mean ovarian cancer is typically not found … Read more -
What to know after a chronic lymphocytic leukemia diagnosisDeborah Stephens, DO, a hematologist and oncologist with UNC Health who specializes in the treatment of chronic lymphocytic leukemia (CLL), shares diagnosis and treatment information about this slow-growing blood cancer. -
UNC research shows natural compound could benefit lymphoma patientsNew UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy. -
UNC researchers develop single sample classifier to predict cancer-associated fibroblast subtypes in patient samplesIn a collaboration between several labs at UNC Lineberger, researchers have defined cancer-associated fibroblast (CAF) subtypes that are clinically robust, prognostic, and predictive of immunotherapy response and developed a clinical … Read more -
UNC Health to add advanced proton therapy for cancer patientsAdvanced cancer treatment will be integrated within UNC Hospitals’ established oncology program — reducing travel, wait times, and burden for patients. -
“Data for everyone”: A new cancer dashboard launches at UNC Lineberger Comprehensive Cancer CenterUNC Lineberger has launched a resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs … Read more